New study: Economic crisis a major barrier to U.S. life settlements market

The life settlements market was hit hard by the economic crisis and other factors in 2008, according to a new study by Conning Research and Consulting.

"The economic crisis was the major impediment to growth in the United States life settlements market in 2008, as the credit markets froze in the second half and life settlements buyers had difficulty financing new premiums," said Scott Hawkins, analyst at Conning Research & Consulting. "In addition, the major life expectancy underwriters revised their methodologies, calling into question the accuracy and valuation of existing portfolios. While there were fewer active buyers in the market, our $11.7 billion estimate of 2008 settled policies did increase our estimate of cumulative in-force life settlements face values."

The Conning Research study, "Life Settlements: A Buyers' Market for Now" presents Conning's estimates of current market size and growth rate, as well as a long term forecast and analysis of market conditions.

"The life settlements market must shake off profitability concerns and general market concerns about life insurer solvency before it will return to growth," said Stephan Christiansen, director of research at Conning. "The buyers' market of late 2008 and 2009 should help buyers re-establish profitability in their portfolios. More policyholders want to sell, and more agents now understand life settlements -- the near term challenge is all about buyers' and investors' capacity."

SOURCE Conning Research & Consulting

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Patient-derived organoids: Transforming cancer research and personalized medicine